ScholarLens Back to search
2014•Clinical Genitourinary CancerOpen access

First-Line Mammalian Target of Rapamycin Inhibition in Metastatic Renal Cell Carcinoma: An Analysis of Practice Patterns From the International Metastatic Renal Cell Carcinoma Database Consortium

Lauren C. Harshman, Nils Kroeger, Sun Young Rha, Frede Donskov, Lori Wood, Srinivas K. Tantravahi, Ulka N. Vaishampayan, Brian I. Rini, Jennifer J. Knox, Scott North, Scott Ernst, Takeshi Yuasa, Sandy Srinivas, Sumanta K. Pal, Daniel Y.C. Heng, Toni K. Choueiri

Open full text 12 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 12 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Renal cell carcinoma, Oncology, Cancer research, Cell culture, Internal medicine, Biology, Genetics

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
First-Line Mammalian Target of Rapamycin Inhibition in Metastatic Renal Cell Carcinoma: An Analysis of Practice Patterns From the International Metastatic Renal Cell Carcinoma Database Consortium — Research Paper | ScholarLens